Clinical Trial Update: Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating minimally invasive surgery with rt-PA for intracerebral hemorrhage evacuation has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• rt-PA (tissue plasminogen activator)

Snippet

Sponsor: Johns Hopkins University | Conditions: Intracerebral Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2019-09-27